Last reviewed · How we verify
NCT07137299: POP-LAP
POPQ Associated With Total Laparoscopic Hysterectomy
trial testing Questionnaire and Physical Exam in Uterine Fibroids (UF) in 2,000 participants. Not yet recruiting.
1 July 2036
Quick facts
| Lead sponsor | Medical University of Silesia |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 October 2025 |
| Primary completion | 1 July 2036 |
| Estimated completion | 1 July 2037 |
| Sites | 4 locations across Poland |
Drugs / interventions tested
- Questionnaire and Physical Exam — full drug profile →
Conditions studied
- Uterine Fibroids (UF) — all drugs for Uterine Fibroids (UF) →
- Abnormal Uterine Bleeding Unrelated to Menstrual Cycle — all drugs for Abnormal Uterine Bleeding Unrelated to Menstrual Cycle →
- Endometrial Hyperplasia — all drugs for Endometrial Hyperplasia →
- Pelvic Organ Prolapse (POP) — all drugs for Pelvic Organ Prolapse (POP) →
Sponsor
Medical University of Silesia
Who can join
Adults 18 to 85, female only, with Uterine Fibroids (UF) or Abnormal Uterine Bleeding Unrelated to Menstrual Cycle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to evaluate the impact of different hysterectomy (removal of the uterus) techniques on the risk of pelvic organ prolapse (situation when one or more of your pelvic organs like your bladder, uterus, or rectum have dropped down or slipped out of their normal position, sometimes even bulging into the vagina) and urinary incontinence (leaking urine unexpectedly) in women aged 18-85 who underwent hysterectomy or supracervical hysterectomy (removing of the uterus without its cervix) for benign (not cancer) conditions. The main question is: to check how different surgical technique (laparoscopic, with opening the abdomen, vaginal and robotic) increase the risk of pelvic organ prolapse or urinary incontinence There is no randomization or control group; comparisons will be made between surgery types based on clinical and questionnaire data. Participants will: * Receive an invitation to participate if they underwent hysterectomy between 2021-2025. * Fill out validated quality of life questionnaires (P-QOL, POPDI-6, PFIQ-7) every two years. * Attend follow-up clinical pelvic exams every two years to assess vaginal cuff healing, pelvic organ prolapses (POP-Q system), and urinary symptoms. This prospective, non-commercial, multicenter study plans to enroll 2,000 women and will run from July 1, 2025, to July 1, 2036
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07137299
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaire and Physical Exam
Trials testing the same drug.
- NCT07469345 — Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men · enrolling by invitation
- NCT06837584 — Control and Treatment of Outpatient Children With Asthma · not yet recruiting
- NCT07521813 — Psychiatric Disorders in Dermatiological Diseases · not yet recruiting
- NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
Other recruiting trials for Uterine Fibroids (UF)
Currently open trials in the same condition.
- NCT06845982 — Anatomopathological Evaluation of a New Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous D · NA · recruiting
- NCT06692335 — HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids · NA · recruiting
Other Medical University of Silesia trials
Trials by the same sponsor.
- NCT06212674 — Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients · Phase 4 · recruiting
- NCT06970041 — To Assess the Types of Mechanical Ventilation in Enabling Therapeutic Bronchofiberoscopy in Patients With Decompensated · NA · not yet recruiting
- NCT06970002 — Respiratory Stabilization in Chronic Acidosis Before Bronchofiberoscopy & Non-Invasive Ventilation Effectivenes · NA · not yet recruiting
- NCT07120529 — Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective M · recruiting
- NCT07058753 — Prehabilitation in Ovarian Cancer Patients During Chemiotherapy Before Cytoreductive Surgery. · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07137299 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Silesia
- Last refreshed: 22 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07137299.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing